Twitter | Search | |
Search Refresh
Bio-Rad Life Science 4h
Is this an example of a safe CAR-T ?
Reply Retweet Like
Takeda 2h
Takeda's President of R&D Andy Plump is presenting our approach to development at the Annual Meeting later this week (Plenary V, June 28, 4:00 p.m. PDT). Learn more about here:
Reply Retweet Like
Patti Cuevas 8h
How cells are thawed is an important consideration in a workflow. What does the evidence show?🤔
Reply Retweet Like
SGLifeSciences 8h
To learn more about our custom solution capabilities, view the catalog here:
Reply Retweet Like
Acorn Biolabs 1h
An experimental trial already showing promise of using your own cells and gene therapy to treat sickle cell disease: "Can Gene Therapy Cure Sickle Cell Disease?"
Reply Retweet Like
Owen Jun 19
Early start this morning to get from Crystal Palace to St Pancras for a 7am train to Sheffield. Looking forward to the annual meeting. But first...coffee.
Reply Retweet Like
Key Biologics, LLC Jun 23
Facilitating is our expertise. How can we accelerate YOUR vital work?
Reply Retweet Like
HemOnc Today 7h
Investigational CAR T-cell therapy induces durable responses in pretreated leukemia subtypes.
Reply Retweet Like
Dr Alok Sharma Jun 20
Being a neurodegenerative disease, can for tackle this challenge?
Reply Retweet Like
SIRION Biotech GmbH Jun 21
SIRION Biotech's Francois Vromman comments on what's happening in one of the world's pioneering countries for and .
Reply Retweet Like
SY Investing Jun 19
A comparison of allogeneic CD19+ CAR-T programs
Reply Retweet Like
Navneet Majhail, MD 25m
Congratulations - you are an inspiration and have touched so many people in - most important are patient lives you have impacted through etc 🙏🙏🙏
Reply Retweet Like
4BIO Capital Jun 20
Managing Partner Dmitry Kuzmin () has been discussing the outlook for venture capital funding of advanced therapies at the Annual Conference this afternoon
Reply Retweet Like

Related searches

@_bsgct
Ross Marklein Jun 18
Excellent webinar today with Drs Robey, and Galipeau on MSCs. Hopefully becomes available on demand to share!
Reply Retweet Like
National MPS Society Jun 21
Treat MPS by changing the blueprint of our kids at a microscopic level! Want to know the "speak"? Second generation therapies
Reply Retweet Like
Owen Jun 21
Great to see a room full of smiles as tells the Annual Conference about his experiences leading Kymriah through to market.
Reply Retweet Like
TrialSite News 1h
Reply Retweet Like
D-BSSE, ETH Zurich Jun 20
Reply Retweet Like
Big4Bio:Philly 4h
Reply Retweet Like
Cure the Future 19h
Cancer affects everyone. Can you support innovative treatment options like CAR T cell therapy? Read on at
Reply Retweet Like